Table 3.
Mean changes in outcomes from baseline to six-week follow-up (3 months for HbA1c levels).
| Parameter | Experimental Group (n = 28) Mean (± SD) | Control Group (n = 28) Mean (± SD) | p-Value Change | ||||
|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | Mean Change | Baseline | Follow-up | Mean Change | ||
| DDS score | 2.47 ± 0.41 | 2.08 ± 0.49 | −0.39 ± 0.47 | 2.46 ± 0.47 | 2.48 ± 0.80 | +0.02 ± 0.62 | 0.006 |
| Food consumption behaviors score | 45.14 ± 7.37 | 50.21 ± 7.03 | +5.07 ± 6.57 | 52.86 ± 6.81 | 52.50 ± 5.07 | −0.36 ± 6.60 | 0.003 |
| Physical Activity | 69.90 ± 57.43 | 76.89 ± 61.39 | +6.99 ± 26.64 | 83.56 ± 92.92 | 92.43 ± 109.88 | +8.87 ± 51.67 | 0.865 |
| Medication taking behaviors score | 21.50 ± 2.03 | 21.89 ± 1.97 | +0.39 ± 1.26 | 22.00 ± 1.94 | 21.46 ± 2.91 | −0.54 ± 2.24 | 0.062 |
| HbA1c% | 9.44 ± 1.63 | 7.34 ± 1.10 | −2.10 ± 1.53 | 9.68 ± 2.09 | 8.97 ± 2.38 | −0.71 ± 2.21 | 0.009 |